XMV:CA:TSX-iShares MSCI Canada Minimum Volatility (CAD)

ETF | Canadian Equity |

Last Closing

CAD 45.52

Change

+0.10 (+0.22)%

Market Cap

CAD 0.23B

Volume

2.61K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-04 )

Largest Industry Peers for Canadian Equity

Symbol Name Price(Change) Market Cap
XIU:CA iShares S&P/TSX 60

+0.29 (+0.80%)

CAD 13.94B
XIC:CA iShares Core S&P/TSX Capped Co..

+0.31 (+0.81%)

CAD 13.18B
ZCN:CA BMO S&P/TSX Capped Composite

+0.26 (+0.81%)

CAD 8.49B
VCN:CA Vanguard FTSE Canada All Cap

+0.42 (+0.85%)

CAD 7.69B
ZLB:CA BMO Low Volatility Canadian Eq..

-0.09 (-0.19%)

CAD 3.97B
HXT:CA Global X S&P/TSX 60™ Index ..

+0.48 (+0.77%)

CAD 3.96B
VCE:CA Vanguard FTSE Canada

+0.45 (+0.86%)

CAD 1.96B
QCN:CA Mackenzie Canadian Equity Inde..

+1.40 (+0.96%)

CAD 1.56B
WXM:CA First Asset Morningstar Canada..

+0.24 (+0.81%)

CAD 0.56B
XESG:CA iShares ESG Aware MSCI Canada ..

+0.29 (+1.01%)

CAD 0.43B

ETFs Containing XMV:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Canadian Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.18% 66% D+ 67% D+
Dividend Return 2.18% 64% D 50% F
Total Return 18.36% 72% C 67% D+
Trailing 12 Months  
Capital Gain 26.41% 72% C 69% C-
Dividend Return 2.96% 64% D 50% F
Total Return 29.37% 76% C+ 70% C-
Trailing 5 Years  
Capital Gain 43.64% 21% F 65% D
Dividend Return 13.97% 71% C- 58% F
Total Return 57.61% 28% F 66% D+
Average Annual (5 Year Horizon)  
Capital Gain 8.27% N/A N/A 65% D
Dividend Return 10.83% N/A N/A 68% D+
Total Return 2.56% N/A N/A 65% D
Risk Return Profile  
Volatility (Standard Deviation) 10.93% N/A N/A 81% B-
Risk Adjusted Return 99.08% N/A N/A 96% N/A
Market Capitalization 0.23B 57% F 48% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.